Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Patient Preferences Regarding Anticoagulation Therapy in Patients with Cancer Having a VTE Event - a Discrete Choice Experiment in the Cosimo Study

Nils Picker, MSc, Alexander T Cohen, MBBS, MSc, MD, Anthony Maraveyas, MD PhD, Jan Beyer-Westendorf, MD, Agnes Yuet Ying Lee, MD MSc, FRCPC, Lorenzo G Mantovani, Yoriko De Sanctis, MS, Khaled Abdelgawwad, Samuel Fatoba, Miriam Bach, Thomas Wilke, Prof. Dr. rer. oec.

Blood (2019) 134 (Supplement_1): 2159.

https://doi.org/10.1182/blood-2019-128095

Published: 2019

Journal Articles

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

Janice Kim, PharmD, MSc, Bindu Kanapuru, MD, Jessica K Roydhouse, PhD MPH, Ann T. Farrell, MD, Najat Bouchkouj, MD, Hussein Ezzeldin, PhD, Paul Kluetz, MD

Blood (2019) 134 (Supplement_1): 3450.

https://doi.org/10.1182/blood-2019-125798

Published: 2019

Journal Articles

Understanding Clinician and Patient Preferences about Novel Agents in Chronic Lymphocytic Leukemia

Hannah Le, PharmD, MPH, Trudy Pendergraft, MSPH, Svea K. Wahlstrom, VMD, MS, Kellie Ryan, MPH, Laura Sarokin, PhD, Emily Mulvihill, MBA, Thomas Campbell, PhD, Martine C. Maculaitis, PhD, Thomas W. LeBlanc, MDMA,MHS

Blood (2019) 134 (Supplement_1): 4730.

https://doi.org/10.1182/blood-2019-129606

Published: 2019

Journal Articles

AML Clinical Trial Decision Making: How Often Do Physicians Follow a Consensus-Derived Assignment Scheme?

Kelda Gardner, PA-C, Mary-Elizabeth M. Percival, MD, Paul C. Hendrie, MD PhD, Anna B. Halpern, MD, Carole M. Shaw, BA, Jacob Appelbaum, MD PhD, Bart L. Scott, MD, Vivian G. Oehler, MD, Roland B. Walter, MD PhD MS, Pamela S. Becker, MD PhD, Elihu H. Estey, MD

Blood (2019) 134 (Supplement_1): 5094.

https://doi.org/10.1182/blood-2019-131280

Published: 2019

Journal Articles

Quantifying Patient Preferences for Treatment Outcomes in AML: A Discrete-Choice Experiment

Daniel R. Richardson, MD MA, Jaein Seo, PharmD, B. Douglas Smith, MD, Elihu H. Estey, MD, Bernadette O'Donoghue, John F.P. Bridges, PhD

Blood (2018) 132 (Supplement 1): 718.

https://doi.org/10.1182/blood-2018-99-113071

Published: 2018

Journal Articles

Patient Preferences for Multiple Myeloma (MM) Treatment: Interim Analysis of a Discrete Choice Experiment

Caroline McKay, PhD, Eric M Maiese, PhD, Joseph Chiarappa, PhD, M. Janelle Cambron-Mellott, PhD, Martine Maculaitis, PhD, Nicole Alunni, MS, Noopur Raje, MD

Blood (2018) 132 (Supplement 1): 3586.

https://doi.org/10.1182/blood-2018-99-112921

Published: 2018

Journal Articles

Patient Preferences Regarding Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients — a Discrete Choice Experiment

Sabrina Mueller, Anna-Katharina Meinecke, Sandra Buchwald, Daniel Eriksson, Thomas Wilke

Blood (2017) 130 (Supplement 1): 4727.

https://doi.org/10.1182/blood.V130.Suppl_1.4727.4727

Published: 2017

Journal Articles

Understanding the Preferences of Patients and Caregivers for Relapsed/Refractory Multiple Myeloma Treatment: A Mixed-Mode Patient-Centric Approach

Daniel Auclair, PhD, Carol Mansfield, PhD, Ajai Chari, MD, Craig E. Cole, MD, Mark A. Fiala, BS, Jonathan L. Kaufman, MD, Gregory Orloff, MD, David Siegel, MD PhD, Jeff A. Zonder, MD, Brennan Mange, Jennifer Yesil, MS, Mehul Dalal, PhD, Joseph Mikhael, MD

Blood (2017) 130 (Supplement 1): 5662.

https://doi.org/10.1182/blood.V130.Suppl_1.5662.5662

Published: 2017

Journal Articles

What Do Patients Prioritize in Selecting Chronic Lymphocytic Leukemia (CLL) Treatments?

Carol Mansfield, PhD, Anthony Masaquel, MPH, PhD, Jessie Sutphin, Elisa S Weiss, PhD, Meghan E. Gutierrez, Jennifer Wilson, Jia Li, PhD, Carolina Reyes, PhD

Blood (2016) 128 (22): 1239.

https://doi.org/10.1182/blood.V128.22.1239.1239

Published: 2016

Journal Articles

Assessing Patient Preferences for the Benefits and Risks of Treating for Acute Myeloid Leukemia (AML): A Pilot Study

Jaein Seo, PharmD, MHS, B. Douglas Smith, MD, Elihu H. Estey, MD, Ernest S. Voyard, Jr., JD, Bernadette O'Donoghue, MPhil, John F. P. Bridges, PhD

Blood (2016) 128 (22): 4799.

https://doi.org/10.1182/blood.V128.22.4799.4799

Published: 2016

Journal Articles

Evaluating Patient Preference for Haemophilia a Treatment

Martin Schulz, Ana Gordo, Chloe Tolley, Hannah Staunton, Elaine Brohan, Dean Spurden, Michael Cicchetti, Joseph C. Cappelleri, PhD MPH, MS

Blood (2016) 128 (22): 4973.

https://doi.org/10.1182/blood.V128.22.4973.4973

Published: 2016

Journal Articles

Rationale for Investigator-Assigned Prophylaxis Dosing Frequency in the Leopold I Study

Thomas J. Humphries, Nikki Church, Shadan Lalezari, Lone H. Poulsen, Mia Yoon, Monika Maas Enriquez

Blood (2016) 128 (22): 4984.

https://doi.org/10.1182/blood.V128.22.4984.4984

Published: 2016

Journal Articles

Title: Progression-Free Survival 2 in Hematological Cancer Treatment Choices: Challenges to Routine Use

Angela Solaman, MHEcon, Andrew Walker, PhD, Faith E Davies, MD

Blood (2016) 128 (22): 5982.

https://doi.org/10.1182/blood.V128.22.5982.5982

Published: 2016

Journal Articles

Age and Cost Are Associated with Patient Preference for Stopping Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

Qian Jiang, Zheng-Chen Liu, Song-Xin Zhang, Jing Li, Robert Peter Gale, MD PhD DSc

Blood (2015) 126 (23): 1585.

https://doi.org/10.1182/blood.V126.23.1585.1585

Published: 2015

Journal Articles

Assessment of Multiple Myeloma Patient Preferences on Treatment Choices: An International Discrete Choice Study

Xavier Leleu, Maria-Victoria Mateos, Michel Delforge, Philip Lewis, Thomas Schindler, Craig Gibson, Min Yang, Katja C. Weisel

Blood (2015) 126 (23): 2086.

https://doi.org/10.1182/blood.V126.23.2086.2086

Published: 2015

Journal Articles

Prefmab: Final Analysis of Patient Preference for Subcutaneous Versus Intravenous Rituximab in Previously Untreated CD20+ Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Mathias Rummel, MD PhD, Tae Min Kim, MD PhD, Caterina Plenteda, MD, Enrico Capochiani, MD, Maria Mendoza, Rodney Smith, MD PhD, Stuart Osborne, MSc, Andrew Grigg, MBBS, MD FRACP, FRACPA

Blood (2015) 126 (23): 3972.

https://doi.org/10.1182/blood.V126.23.3972.3972

Published: 2015

Journal Articles

Prognostic Disclosure in Acute Myeloid Leukemia (AML): A Qualitative Study of Patient Preferences and Physician Practices

Thomas W. LeBlanc, MD MA, Catherine T Bloom, Debra M Davis, RN, Susan C Locke, PhD, Karen E Steinhauser, PhD, Peter A Ubel, MD, James A Tulsky, MD, Amy P Abernethy, MD PhD

Blood (2014) 124 (21): 1280.

https://doi.org/10.1182/blood.V124.21.1280.1280

Published: 2014

Journal Articles

Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Rachel MA Kyle, BSc, Alejandro Lazo-Langner, MD, MSc, Anargyros Xenocostas, MD, FRCPC, Ian H. Chin-Yee, MD, FRCPC, Kang Howson-Jan, MD, David Sanford, MD, Cyrus C. Hsia, BSc, MD, FRCPC

Blood (2012) 120 (21): 4274.

https://doi.org/10.1182/blood.V120.21.4274.4274

Published: 2012

Journal Articles

Ambulatory Patient Preference for VTE Prophylaxis

Tarek Sousou, Alok Khorana

Blood (2008) 112 (11): 4709.

https://doi.org/10.1182/blood.V112.11.4709.4709

Published: 2008

Journal Articles

Early Results from a Choice Based Conjoint Analysis Assessing Patient Preferences for Selected Features of Erythropoietic Agents.

Susan C. Bolge, PhD, John M. Fastenau, MPH, RPh, Jamie B. Howell, PharmD, MS, Catherine T. Piech, MBA, Jane A. Donohue, PhD

Blood (2004) 104 (11): 5307.

https://doi.org/10.1182/blood.V104.11.5307.5307

Published: 2004

NARROW

Patient Preferences Regarding Anticoagulation Therapy in Patients with Cancer Having a VTE Event - a Discrete Choice Experiment in the Cosimo Study

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

Understanding Clinician and Patient Preferences about Novel Agents in Chronic Lymphocytic Leukemia

AML Clinical Trial Decision Making: How Often Do Physicians Follow a Consensus-Derived Assignment Scheme?

Quantifying Patient Preferences for Treatment Outcomes in AML: A Discrete-Choice Experiment

Patient Preferences for Multiple Myeloma (MM) Treatment: Interim Analysis of a Discrete Choice Experiment

Patient Preferences Regarding Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients — a Discrete Choice Experiment

Understanding the Preferences of Patients and Caregivers for Relapsed/Refractory Multiple Myeloma Treatment: A Mixed-Mode Patient-Centric Approach

What Do Patients Prioritize in Selecting Chronic Lymphocytic Leukemia (CLL) Treatments?

Assessing Patient Preferences for the Benefits and Risks of Treating for Acute Myeloid Leukemia (AML): A Pilot Study

Evaluating Patient Preference for Haemophilia a Treatment

Rationale for Investigator-Assigned Prophylaxis Dosing Frequency in the Leopold I Study

Title: Progression-Free Survival 2 in Hematological Cancer Treatment Choices: Challenges to Routine Use

Age and Cost Are Associated with Patient Preference for Stopping Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

Assessment of Multiple Myeloma Patient Preferences on Treatment Choices: An International Discrete Choice Study

Prefmab: Final Analysis of Patient Preference for Subcutaneous Versus Intravenous Rituximab in Previously Untreated CD20+ Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Prognostic Disclosure in Acute Myeloid Leukemia (AML): A Qualitative Study of Patient Preferences and Physician Practices

Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Ambulatory Patient Preference for VTE Prophylaxis

Early Results from a Choice Based Conjoint Analysis Assessing Patient Preferences for Selected Features of Erythropoietic Agents.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only